Table of Contents Table of Contents
Previous Page  123 / 172 Next Page
Information
Show Menu
Previous Page 123 / 172 Next Page
Page Background

e184

Abstracts of the 22

nd

National Congress of Digestive Diseases / Digestive and Liver Disease 48S2 (2016) e67–e231

inspection of the slides by the endosonographer, in the absence of a

microscopic rapid on-site evaluation (ROSE), can increase FNA

adequacy, thus allowing to complete the procedure with a limited

number of needle passes.

Material and methods:

We retrospectively evaluated our FNA

procedures on solid pancreatic lesions when the cytopathologist

was absent and the endosonographer smeared, observed and fixed

the slides by himself. A standard 22G or 25G needle was moved

in the target lesion without suction and the aspirated material

was expelled on slides by blowing air. The slides were smeared

and observed with oblique white light: when thin granular or

filamentous whitish or pink material was visible and blood was

poor, the slides were considered adequate and they were fixed with

alcohol. When blood or clots were predominant the smears were

eliminated. When no material was present in the needle, suction

was applied in the next needle passes. The procedure was closed,

regardless of the number of needle passes, when 5 slides were

judged satisfactory. For each case the number of needle passes and

the final microscopic adequacy were recorded.

Results:

Overall 100 patients entered the study. A mean of 4.1

(range 1-7) needle passes were effected. Microscopic adequacy

was achieved in 95 cases (95.0%): 74 pancreatic adenocarcinoma,

3 neuroendocrine tumor, 3 atypical pancreatic cells, 11 benign

pancreatic cells, 2 lymphoma, 2 benign lymphocytes. Most

procedures were ruled out with a 22G needle, which got an adequate

sample in 79 out of 84 (94.0%) cases; the 25G needle was used only

16 times, all resulting adequate (100%) (p = n.s.). No complications

occurred.

Conclusions:

Although the best technique for improving the

performance of pancreatic FNA still seems ROSE, either its cost or its

low diagnostic gain in centers with an already high accuracy limits

its availability. We suggest a simple, rapid and cheap alternative

to ROSE; the visual inspection of the smeared slides could help

choosing those with abundant diagnostic material, hence increasing

FNA adequacy and reducing the number of needle passes.

P.11.8

THE ROLE OF EUS-FNA IN THE DIAGNOSIS OF PANCREATIC

NEUROENDOCRINE TUMORS

Carrara S.*, Rahal D., Zerbi A., Anderloni A., Di Leo M.,

Di Tommaso L., Loriga A., Federico D., Repici A.

Humanitas Research Hospital, Rozzano, Italy

Background and aim:

One of the most controversial issue in the

diagnosis of pancreatic neuroendocrine tumors (NET) is the accurate

prediction of their clinical behaviour. According to the ENETS and

WHO 2010 criteria the grading for pancreatic NET has to be expressed

by using the mitotic index and the Ki67 proliferation index. The aim

of this study was to evaluate the of the EUS-FNA in the diagnosis and

grading of pancreatic NET.

Material and methods:

We retrospectively reviewed all consecutive

patients referred to our Unit with a radiological finding suspicious

for NET.A computerized system was used to extrapolate the list of

patients with NET in the field of pancreatic EUS between May 2014

and Oct 2015. EUS was performed with the linear array Olympus

GF-UCT-180 series echoendoscopes in combination with the

echoprocessor EU-ME2. FNA was performed with Beacon or Boston

Scientific 25G or 22G needles. Forty-nine patients undergoing EUS

were identified with 24 having also FNA. Adequacy of the aspirated

material was assessed by Rapid On Site Evaluation (ROSE) and

fragments observed on slide at macroscopic evaluation were placed

in formalin for histology evaluation. In patients undergoing surgery

the EUS-FNA results were compared with final histological diagnosis.

Results:

Patients population included 9 women and 15 male (mean

age 58 years). Fourteen patients (58%) had an incidental finding of

pancreatic mass, 2 (9%) had genetic syndrome and the others (33%)

had symptoms like pain, weight loss or jaundice. All the cases were

non-functioning. Clinical and technical data are summarized in the

Table. In 2 cases the procedure was interrupted before the adequacy

was obtained because of a mild self-limited bleeding. The

combination of cytology and histology reached an adequacy of 92%

(the 2 inadequate cases were those in which a bleeding was

observed) and gave a ki67 result in 15 cases (62.5%). The final

diagnosis was obtained with EUS-FNA in 22 cases (92%). Six patients

underwent surgery (25%): 4 distal pancreatectomy, one enucleation,

and one Whipple resection; 8 patients are waiting for surgery; 4 are

in follow up, 1 had chemotherapy, 5 are lost at follow up. In 3

patients who underwent surgery who had a ki67 result on the EUS-

FNA report, there was a 100% correspondence between FNA and

resected specimen.

Conclusions:

The combination of cytology and histology from EUS-

FNA is an effective method for the diagnosis of pancreatic NET and

ki67 index grading for WHO 2010 classification.

P.12 Coeliac Disease 2

P.12.1

GLUTEN-FREE DIET DOES NOT INFLUENCE THE OCCURRENCE

AND THE TH1/TH17-TH2 NATURE OF IMMUNE-MEDIATED

DISEASE IN PATIENTS WITH COELIAC DISEASE

Imperatore N.*

1

, Tortora R.

1

, Capone P.

1

, Donetto S.

2

, De Palma G.D.

3

,

Gerbino N.

1

, Rea M.

1

, Caporaso N.

1

, Rispo A.

1

1

Gastroenterology “Federico II” University, Naples, Italy,

2

Department

of Education and Professional Studies, King’s College London, London,

United Kingdom,

3

Surgical Endoscopy “Federico II” University, Naples,

Italy

Background and aim:

Even though coeliac disease (CD) is

considered to be the most common lymphocyte T helper-1 (Th-1)

mediated enteropathy in Western countries, it seems that Th1-

and lymphocyte T helper-2 (Th-2 )-mediated diseases could co-

exist in CD patients. The aims of the study were: 1) to establish the

prevalence of immune-mediated disorders at time and after CD

diagnosis; 2) to evaluate a possible change in immune response after

starting gluten free diet (GFD); 3) to investigate the potential role of

GFD in reducing and/or preventing immune-mediated disorders in

adult CD patients.

Material and methods:

We carried out a database-driven study

including all consecutive adult CD patients followed-up at our

Gastrointestinal Unit. CD diagnosis was made in accordance with the